Posted in | News | Energy

Status Report on World's Larget Fusion Experiment

The second meeting of the Interim ITER Council (IIC) took place on 11 and 12 July in Tokyo, under the Chairmanship of Sir Christopher Llewellyn Smith, CCE-EU Chairman (EU). The meeting came about half a year after its first meeting held immediately after the signature in Paris, 21 November 2006, of the Agreement on the Joint Implementation of ITER, the world’s largest fusion energy experiment that is aimed at establishing the scientific and technological feasibility of fusion as an energy source for peaceful purposes.

At the outset of the meeting, the IIC noted the progress made by the signatories in ratifying the ITER Agreement. The process is almost complete and the Agreement is now expected to enter into force within the next months.

Mr Kaname Ikeda, Nominee Director-General, of the ITER Organization and his principal deputy, Mr Norbert Holtkamp, reported on the ramp up of project activities under the provisional application of the ITER Agreement, including the assembly of the project team at the Cadarache site, the design review of the ITER facilities, the development and deployment of management tools to match ITER’s unique project structure, the preparation of detailed specifications for procuring ITER components and the start of engineering work at the site.

The IIC recognized the progress being made and gave direction on a number of specific points, including the plans and detailed staffing and cost estimates for the construction phase, specific aspects of the management system and proposed agreements on relations with French authorities and with other international organizations, the IAEA, and CERN. The IIC also endorsed a proposed partnership arrangement with the Principality of Monaco.

The Chairman, Sir Christopher Llewellyn Smith summed up: “The progress reported and the constructive discussions that took place during the meeting bode well for the future. The important and unprecedented international ITER collaboration is now taking the first steps to fruition.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.